Carlyle ends boardroom spat at India's Metropolis

The US private equity firm's purchase of a stake in the pathology laboratories chain signals an end to a boardroom battle triggered by Warburg Pincus' exit earlier this year.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition